Le Lézard

Co-PSMA abstract accepted for oral presentation at EAU Annual Congress 2026

Clarity Pharmaceuticals ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with ...
Vietnam Investment Review on MSN

Caliway submits CBL-514 for FDA Phase 2 weight management trial

Caliway Biopharmaceuticals (TWSE: 6919) today announced that it has completed the submission of an Investigational New Drug (IND) application to the U.S. FDA for a Phase 2 clinical study of its ...

The whoppers of 2025

With President Donald Trump back in the White House in 2025, it’s no surprise that he dominates the FactCheck.org year-end ...
Medindia

Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA ...

Caliway Biopharmaceuticals (TWSE: 6919) today announced that it has completed the submission of an Investigational New Drug (IND) application to the U.S. FDA for a Phase 2 clinical study of its ...

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

Galectin Therapeutics Inc. is rated a Hold due to absence of finalized agreement with FDA, combined with a tight runway. Read ...
The American Journal of Managed Care

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

This study found that certain characteristics in linked electronic health record data across episodes of care can help identify patients with Alzheimer disease and related dementias at high risk of 30 ...

Eli Lilly: Mr. Market Finally Woke Up, But I'm Not Out Yet (Rating Downgrade)

Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm still bullish on LLY stock.
Le Lézard

Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC

Agenus Inc. , a leader in immuno-oncology innovation, today announced the publication of clinical results from the ovarian cancer cohort of its Phase 1b C-800-01 trial evaluating botensilimab plus ...

Caliway Biopharmaceuticals: Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding ...

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 ...
BMJ Open

Using virtual twin-based AI models to detect atrial fibrillation and improve stroke outcomes [TAILOR]: a multicentre prospective cohort study

Introduction Atrial fibrillation (AF) is the leading cause of cardioembolic stroke and is associated with increased stroke severity and fatality. Early identification of AF is essential for adequate ...
Open Heart

Impact of depression on medication non-adherence in coronary artery disease: a systematic review and meta-analysis

Background Depression is a risk factor and complication of coronary artery disease (CAD) that is associated with poor ...
BMJ Open

Site-randomised trial of a multilevel digital intervention to reduce maternal morbidity and mortality: a study protocol

Introduction Compared with other high-income countries, the USA continues to have the highest rates of pregnancy-related and associated mortality and morbidity (PRAMM), particularly in rural areas and ...